CPC A61K 31/519 (2013.01) [A61K 31/122 (2013.01); A61K 31/37 (2013.01); A61K 31/4365 (2013.01); A61K 31/4465 (2013.01); A61K 31/616 (2013.01); A61K 31/702 (2013.01); A61K 31/727 (2013.01); A61K 38/12 (2013.01); A61K 38/482 (2013.01); A61K 39/3955 (2013.01); C07D 513/04 (2013.01); C07B 2200/05 (2013.01)] | 20 Claims |
1. A compound of Formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
each of Ra, Rb, Rc, Rd, R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13, R14, and R15 independently are hydrogen or deuterium;
provided that at least one of R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13, R14, and R15 is deuterium.
|